Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -6 of 6
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care, Treatment
Active
18 and over
Other
2006-00055-18
NCT00415103
Last Modified:
6/10/2008
 
First Published:
7/1/2002
2.
Phase II/III Randomized Study of Ginger for Chemotherapy-Related Nausea in Patients With Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Supportive care
Active
18 and over
NCI
URCC-U1902
URCC-0114, NCI-5857, NCI-P02-0223, NCT00040742
Last Modified:
5/29/2008
 
First Published:
5/11/2007
3.
Phase III Randomized Study of Different Combinations of Granisetron Hydrochloride, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron Hydrochloride in Preventing Delayed Nausea in Women Undergoing Chemotherapy for Chemotherapy-Naive Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
NCI
URCC-04-02
URCC 0402, URCC-U1105, U1105, NCT00475085
4.
Efficacy and Safety of Aprepitant in Subjects With Multiple Myeloma During and After High-Dose Chemotherapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Other
EmNa (2001-004956-38)
EudraCT-No: 2004-004956-38, NCT00571168
Last Modified:
6/9/2008
 
First Published:
1/25/2007
5.
Phase II Randomized Study of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients With Newly Diagnosed Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care
Active
8 to 18
NCI
MCC-0503
HLMCC 0503, NCT00429702
Last Modified:
8/23/2008
 
First Published:
2/10/2006
6.
Pilot Study of Aprepitant, Granisetron Hydrochloride, and Dexamethasone in Patients With Nausea and Vomiting Due to Therapy Comprising High Dose Cyclophosphamide Prior to Autologous Peripheral Blood Stem Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care, Treatment
Active
Over 18
NCI
WSU-D-2797
WSU-0504001728, NCT00293384
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute